Pipeline variability: Friend or foe, depending on the goal: Comment on Germani et al. 2025. [PDF]
Zhang LB, Wager TD.
europepmc +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
The influence of social capital on college students' academic adaptation: the mediating role of positive emotional experience. [PDF]
Tong Q, Cheng J, Yang Y.
europepmc +1 more source
AFFECTIVE INFORMATION INFLUENCES AFFECTIVE EVALUATION BUT NOT AFFECTIVE EXPECTATION
openaire +2 more sources
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
The impact of self-control on aggressive behavior: the chained mediating role of hostile attribution bias and positive/negative implicit affect. [PDF]
Ma Q, Wang X, Liu L.
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Self-Compassion Components and Emotional Regulation Strategies as Predictors of Psychological Distress and Well-Being. [PDF]
Ranjouri S, Meyer D, Bates GW.
europepmc +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source

